AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 AC Immune to host symposium highlighting…
Company successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core at the University of…
Demonstrated substantial and statistically significant improvement in ADHD symptoms as measured by the AISRS total score compared to placebo (p=0.039,…
In February 2025, BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion…
Toronto, Ontario--(Newsfile Corp. - March 24, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that…
A leading U.S.-based drug delivery device company known for its strong global commercial presence recognized this opportunity and aimed to…
BURLINGTON, Mass., March 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social,…
ABU DHABI, UAE, March 24, 2025 /PRNewswire/ -- The UAE capital, Abu Dhabi, is preparing to welcome over 25,000 participants, distinguished…
CARY, N.C., March 24, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of electronic batch record (EBR), manufacturing execution system (MES),…
TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…